79 related articles for article (PubMed ID: 21778310)
41. Interstitial Brachytherapy for Limited (<4 cm) and Large (≥4 cm) Hepatic Metastases from Rare and Less Common Cancers.
Heinze C; Omari J; Damm R; Hass P; Brunner T; Surov A; Seidesticker R; Seidensticker M; Ricke J; Powerski M; Pech M
Anticancer Res; 2020 Aug; 40(8):4281-4289. PubMed ID: 32727755
[TBL] [Abstract][Full Text] [Related]
42. Is there always a need for invasive treatment of limited liver metastases in renal cell cancer or other solid tumors?
Bruns F; Christiansen H
World J Urol; 2015 Mar; 33(3):443-4. PubMed ID: 24880999
[No Abstract] [Full Text] [Related]
43. Hepatic metastases from granulosa cell tumor of the ovary: CT and sonographic findings.
Neste MG; Francis IR; Bude RO
AJR Am J Roentgenol; 1996 May; 166(5):1122-4. PubMed ID: 8615255
[No Abstract] [Full Text] [Related]
44. Evidence-based integration of selective internal radiation therapy in the management of colorectal liver metastases.
Wasan HS
Future Oncol; 2014 Nov; 10(15 Suppl):33-6. PubMed ID: 25478764
[No Abstract] [Full Text] [Related]
45. Evidence-based integration of selective internal radiation therapy into the management of breast cancer liver metastases.
Cianni R; Pelle G
Future Oncol; 2014 Nov; 10(15 Suppl):93-5. PubMed ID: 25478777
[No Abstract] [Full Text] [Related]
46. Supraumbilical rash caused by nontarget radioembolization to the falciform artery.
Sharma AK; Foster TH; Katz A; Lee DE; Waldman DL
J Vasc Interv Radiol; 2014 Mar; 25(3):483-4. PubMed ID: 24581472
[No Abstract] [Full Text] [Related]
47. Latest selective internal radiation therapy recommendations from EU proctors.
Maleux G
Future Oncol; 2014 Nov; 10(15 Suppl):69-72. PubMed ID: 25478772
[No Abstract] [Full Text] [Related]
48. [Intra-abdominal radiocolloid administration: indications, complications, results].
Vahrson H
Arch Gynecol Obstet; 1987; 242(1-4):384-90. PubMed ID: 3688960
[No Abstract] [Full Text] [Related]
49. Narrative Review of High-Dose-Rate Interstitial Brachytherapy in Primary or Secondary Liver Tumors.
Karagiannis E; Strouthos I; Leczynski A; Zamboglou N; Ferentinos K
Front Oncol; 2022; 12():800920. PubMed ID: 35299745
[TBL] [Abstract][Full Text] [Related]
50. Addressing hepatic metastases in ovarian cancer: Recent advances in treatment algorithms and the need for a multidisciplinary approach.
Adamopoulou K; Gkamprana AM; Patsouras K; Halkia E
World J Hepatol; 2021 Sep; 13(9):1122-1131. PubMed ID: 34630879
[TBL] [Abstract][Full Text] [Related]
51. Treatment of hepatic pancreatic ductal adenocarcinoma metastases with high-dose-rate image-guided interstitial brachytherapy: a single center experience.
Drewes R; Omari J; Manig M; Seidensticker M; Hass P; Ricke J; Powerski M; Pech M
J Contemp Brachytherapy; 2019 Aug; 11(4):329-336. PubMed ID: 31523233
[TBL] [Abstract][Full Text] [Related]
52. Radioablation of liver malignancies with interstitial high-dose-rate brachytherapy : Complications and risk factors.
Mohnike K; Wolf S; Damm R; Seidensticker M; Seidensticker R; Fischbach F; Peters N; Hass P; Gademann G; Pech M; Ricke J
Strahlenther Onkol; 2016 May; 192(5):288-96. PubMed ID: 26923394
[TBL] [Abstract][Full Text] [Related]
53. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
[TBL] [Abstract][Full Text] [Related]
54. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566
[TBL] [Abstract][Full Text] [Related]
55. Computed tomography-guided brachytherapy for liver cancer.
Ricke J; Wust P
Semin Radiat Oncol; 2011 Oct; 21(4):287-93. PubMed ID: 21939858
[TBL] [Abstract][Full Text] [Related]
56. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis.
Weitmann HD; Pötter R; Waldhäusl C; Nechvile E; Kirisits C; Knocke TH
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):468-78. PubMed ID: 15890589
[TBL] [Abstract][Full Text] [Related]
57. CT-guided high-dose-rate brachytherapy of metachronous ovarian cancer metastasis to the liver: initial experience.
Collettini F; Poellinger A; Schnapauff D; Denecke T; Wust P; Braicu IE; Sehouli J; Hamm B; Gebauer B
Anticancer Res; 2011 Aug; 31(8):2597-602. PubMed ID: 21778310
[TBL] [Abstract][Full Text] [Related]
58. Treatment of hepatic metastases from gastric or gastroesophageal adenocarcinoma with computed tomography-guided high-dose-rate brachytherapy (CT-HDRBT).
Geisel D; Denecke T; Collettini F; Grieser C; Wust P; Thuss-Patience P; Hamm B; Gebauer B
Anticancer Res; 2012 Dec; 32(12):5453-8. PubMed ID: 23225451
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
